Latest News - Page 11

Daklinza Approved in UK for Genotype 3 Hepatitis C Treatment
BY CATHERINE KOLONKO
The once daily oral medication is for use with Sovaldi with or without ribavirin or in combination with peginterferon alfa and ribavirin.
Analysis of Lipoproteins in the HCV Life Cycle May Lead to Better Treatments
BY CARLY SZABO
Link found between between HCV infectivity and lipoprotein metabolism.
Gilead Seeks Approval for Hepatitis C Treatment for All Genotypes
BY KRYSTLE VERMES
Once-daily combination would be the first all-oral, pan-genotypic single tablet for treatment of HCV.
Colitis Reported with Drug Combination in HCV Treatment
BY MICHAEL R. PAGE, PHARMD, RPH
A commonly used direct-acting antiviral combination for treatment of hepatitis C may have an unexpected side effect.
Life Changing HCV Treatment Highlights Hepatitis C Week in Review
BY DAVY JAMES, MANAGING EDITOR
Top stories of the week on CURE Hepatitis C.
Panel Recommends New Drugs for Nearly All Chronic HCV Cases
BY CATHERINE KOLONKO
Which patients actually treated with new antiviral drugs dependent on availability and higher costs.
Depression and HCV: Prevalence and Prevention
BY CARLY SZABO
Side effects from interferon can include a significant impact on mental health.
Air Pollution May Worsen Liver Disease
BY RACHEL LUTZ
Pollutants may accelerate fibrosis, metabolic disease, and liver cancer.
$auto_registration$